News Details

( As on 06/03/2026 15:36)

Alembic Pharmaceuticals enters US branded pharma market; begins antibiotic sales

Alembic Pharmaceuticals on Friday announced its entry into the US branded pharmaceutical segment with the commencement of sales of an oral penicillin-class antibiotic.

The company has started marketing Pivya (pivmecillinam) tablets following their recent commercial launch in the United States.

Pivya marks Alembic’s first branded pharmaceutical product in the US and is being distributed through Alembic Therapeutics LLC, a step-down wholly owned subsidiary of the company.